can you take glp 1 with crohn's disease GLP-1 Disease: Safety, Risks and Clinical Guidance – Bolt Pharmacy Frontiers | GLP-1 and GLP-2

Krishnan A, Patel RA, Hadi YB et al (2023) Clinical characteristics and outcomes of COVID-19 in patients with autoimmune hepatitis: a population-based matched cohort study

In summary, GLP-1RA could reduce the proliferation of effector T cells, promote the generation of Treg cells, and enhance the immunosuppressive function of Treg cells ( Figure 3 ) (91)

Electrolyte Blood Press (2013) 11(2):415

Pooled mean follow-up on-treatment for semaglutide users was 193 days (median 157 days, interquartile range (IQR) 85 to 331 days) and for sitagliptin users 195 days (median 160 days, IQR 95 to 322 days)

This hormone helps regulate appetite, manage blood sugar, and slow digestion